https://doi.org/10.4081/aiua.2015.4.312

Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs

Vol. 87 No. 4 (2015)
Submitted: January 12, 2016
Accepted: January 12, 2016
Published: January 14, 2016
5-alpha-reductase inhibitors (5ARIs), Sexual dysfunctions, Benign prostatic hyperplasia (BPH), Androgenetic alopecia
Abstract Views: 3986
PDF: 2904
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Furio Pirozzi Farina
andro@tin.it
Andrological Urology Unit, AOU di Sassari, Sassari, Italy.
Antonella Pischedda
Andrological Urology Unit, AOU di Sassari, Sassari, Italy.
Treatment-induced sexual dysfunctions (SD) are a recurrent and controversial topic in recent literature on the adverse events related to the use of 5-alpha-reductase inhibitors (5ARIs) (1, 2). In order to deal adequately with the various aspects of this topic, it is necessary to first cover some of the steps that allow a better definition and understanding of the subject.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Pirozzi Farina, F., & Pischedda, A. (2016). Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs. Archivio Italiano Di Urologia E Andrologia, 87(4), 312–316. https://doi.org/10.4081/aiua.2015.4.312

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.